V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Portfolio 13F
Dodge & Cox Stock Fund Holdings Activity
- Portfolio value:
- $109.11B≈ (-$472M≈)
- Previous value:
- $109.59B≈
- # of changes:
- 21
- New positions:
- 2
- Reported for:
- 30 Jun 2024 (Q2)
- Latest filing date:
- 27 Aug 2024
Dodge & Cox Stock Fund has disclosed a total of 21 changes to the portfolio in the (2024 Q2) SEC report(s): increased the number of shares of 7, bought 2 totally new, decreased the number of shares of 10 and completely sold out 2 position(s).
What stocks did Dodge & Cox Stock Fund buy in 2024 Q2?
During 2024 Q2 Dodge & Cox Stock Fund has bought 9 securities out of which top 5 purchases (by % change to portfolio) were (JCI) Johnson Controls International PLC (added shares +8.93%), (CVS) CVS Health Corp (added shares +49.70%), (NSC) Norfolk Southern Corp (added shares +34.06%), (HUM) Humana Inc (new buy) and (AVTR) Avantor Inc (added shares +5.17%).
What did Dodge & Cox Stock Fund invest in during 2024 Q2?
21 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Humana Inc
|
new
|
+2,880,956
|
2,880,956
|
+0.99%
|
$373.65
|
-1.92%($366.46)
|
0.99%
|
2024 Q2
|
≈ 0.25 years
|
|
|
|
ASHTEAD GROUP PLC
|
new
|
+11,157,360
|
11,157,360
|
+0.68%
|
$66.63
|
|
0.68%
|
2024 Q2
|
≈ 0.25 years
|
|
|
|
CVS Health Corp
|
+49.70%
|
+13,688,600
|
41,232,500
|
+0.74%
|
$59.06
|
+78.23%($105.26)
|
2.23%
|
2019 Q3
|
≈ 5.00 years
|
|
|
|
Norfolk Southern Corp
|
+34.06%
|
+1,771,700
|
6,974,000
|
+0.35%
|
$214.69
|
+56.14%($335.22)
|
1.37%
|
2023 Q2
|
≈ 1.25 years
|
|
|
|
VF Corp
|
+16.61%
|
+3,903,700
|
27,401,600
|
+0.05%
|
$13.50
|
+6.74%($14.41)
|
0.34%
|
2023 Q3
|
≈ 1.00 year
|
|
|
|
STATE ST INST US GOV MM-PREM
|
+9.35%
|
+56,324,723.8
|
658,416,345.47
|
+0.05%
|
$1.00
|
0.00%($1.00)
|
0.60%
|
2019 Q3
|
≈ 5.00 years
|
|
|
|
Johnson Controls International PLC
|
+8.93%
|
+3,423,647
|
41,748,217
|
+0.21%
|
$66.47
|
+120.51%($146.58)
|
2.54%
|
2019 Q3
|
≈ 5.00 years
|
|
|
|
Avantor Inc
|
+5.17%
|
+2,092,100
|
42,554,915
|
+0.04%
|
$21.20
|
-35.47%($13.68)
|
0.83%
|
2023 Q3
|
≈ 1.00 year
|
|
|
|
Neurocrine Biosciences Inc
|
+0.74%
|
+5,140
|
700,288
|
+0%
|
$137.67
|
+20.98%($166.56)
|
0.09%
|
2023 Q3
|
≈ 1.00 year
|
|
|
|
Alphabet Inc, CL-C
|
-3.23%
|
-588,200
|
17,595,660
|
-0.1%
|
$183.42
|
+92.95%($353.90)
|
2.96%
|
2019 Q3
|
≈ 5.00 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.